Skip to main content
Premium Trial:

Request an Annual Quote

BforCure Gets CE-IVD Mark for Molecular SARS-CoV-2 Test Kit

NEW YORK — BforCure said last week that it has received CE-IVD marking for its Bfast SARS-CoV-2 RT-PCT kit.

The kit is designed to detect two SARS-CoV-2 genes. It runs on the company's Chronos Dx in vitro diagnostic PCR platform and provides results within 15 minutes.

Last month, Paris-based BforCure raised €2 million ($2.3 million) from ID-Solutions to adapt Chronos Dx to detect cancers.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.